Wall Street Zen lowered shares of Nukkleus (NASDAQ:DFNS – Free Report) from a sell rating to a strong sell rating in a report published on Saturday morning.
A number of other equities analysts have also recently issued reports on the stock. Weiss Ratings cut shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. Noble Financial upgraded shares of Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.
Check Out Our Latest Stock Analysis on DFNS
Nukkleus Price Performance
Nukkleus (NASDAQ:DFNS – Get Free Report) last issued its earnings results on Wednesday, May 20th. The company reported ($142.50) EPS for the quarter. The company had revenue of $3.65 million during the quarter. Sell-side analysts predict that Nukkleus will post -4.21 earnings per share for the current year.
Institutional Trading of Nukkleus
Large investors have recently bought and sold shares of the stock. LPL Financial LLC bought a new position in shares of Nukkleus during the fourth quarter valued at $120,000. Geode Capital Management LLC grew its holdings in shares of Nukkleus by 193.7% in the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock worth $503,000 after purchasing an additional 82,252 shares during the last quarter. Ausdal Financial Partners Inc. acquired a new stake in shares of Nukkleus during the 3rd quarter worth about $105,000. UBS Group AG increased its position in shares of Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after purchasing an additional 15,223 shares in the last quarter. Finally, Millennium Management LLC bought a new position in Nukkleus during the 4th quarter valued at about $60,000. 12.47% of the stock is currently owned by institutional investors.
About Nukkleus
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
Featured Articles
- Five stocks we like better than Nukkleus
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
